We're excited to announce that Eagle Genomics is one of 12 companies selected from 300 to be part of Cohort 9 of the Microsoft ScaleUp program.
Selected from 4,000 nominated companies, Eagle Genomics will present its latest technology and growth trajectory to an exclusive audience of innovators, investors and business leaders
Eagle Genomics and the Stratified Medicine Scotland Innovation Centre (SMS-IC) have been awarded a £1.7M collaborative grant from Innovate UK (the UK’s..
We'll be exhibiting at this year's Festival of Genomics, join us on stand D16 and meet the 'Automated Data Scientist', our smart knowledge discovery platform.
Eagle Genomics is making much use of open data on behalf of its customers to help them identify competitive advantage from their own data.
December 2017, Cambridge, UK
Eagle Genomics is pleased to announce the appointment of Nicola Blackwood to its Advisory Board. Nicola brings a wealth of experience from a parliamentary career which included positions as Chair of the Science &..
Selecting valuable patient cohorts for cancer biomarker discovery
Providing a scientist with prioritised datasets based on their scientific relevance to the research that the scientist wants to carry forward, allows for improved data selection,..
Join a panel of experts, including Alexandre Passioukov, VP Translational Medicine at Pierre Fabre, Xose Fernandez, Chief Data Officer at Institut Curie and Abel Ureta-Vidal, CEO at Eagle Genomics, as they discuss their first-hand experience of..
Content is something we're never short of. In a digital world, information is never more than a click of a button away through search, social media, bloggers, apps... and constantly accessible through various devices.
Over the last 3 years, Eagle has been involved in a EU funded project, sysVASC, a bench to bedside program with a systems biology approach to identify new targets of disease progression in cardio-vascular disease. This disease killed an estimated